» Articles » PMID: 1372185

Defective Glycosylphosphatidylinositol Anchor Synthesis in Paroxysmal Nocturnal Hemoglobinuria Granulocytes

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1992 Mar 15
PMID 1372185
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the biosynthesis of the glycosylphosphatidylinositol (GPI) anchor in the granulocytes of paroxysmal nocturnal hemoglobinuria (PNH), the glycolipids of granulocytes from PNH patients and normal volunteers were biosynthetically labeled with [3H]mannose in the presence of tunicamycin. Extracted glycolipids were examined by thin-layer chromatography and compared with known biosynthetic intermediates. Normal granulocytes consistently showed [3H]mannose incorporation into the complete GPI core, several GPI biosynthetic intermediates, and dolichol phosphate mannose (DPM). The granulocytes of 10 patients with PNH that had no expression of CD55 and CD59 on greater than 95% of the cells were able to incorporate [3H]mannose into DPM, but were not able to incorporate detectable amounts into the complete GPI core. THus, PNH granulocytes do not synthesize detectable amounts of the complete GPI core and this defect likely accounts for the absence of GPI-linked membrane proteins on hematopoietic cells in this syndrome.

Citing Articles

Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.

Hillmen P, Horneff R, Yeh M, Kolev M, Deschatelets P Int J Mol Sci. 2024; 25(17).

PMID: 39273426 PMC: 11395449. DOI: 10.3390/ijms25179477.


CD59 gene: 143 haplotypes of 22,718 nucleotides length by computational phasing in 113 individuals from different ethnicities.

Srivastava K, Yin Q, Makuria A, Rios M, Gebremedhin A, Flegel W Transfusion. 2024; 64(7):1296-1305.

PMID: 38817044 PMC: 11251854. DOI: 10.1111/trf.17869.


A novel homozygous PIGO mutation associated with severe infantile epileptic encephalopathy, profound developmental delay and psychomotor retardation: structural and 3D modelling investigations and genotype-phenotype correlation.

Aguech A, Sfaihi L, Alila-Fersi O, Kolsi R, Tlili A, Kammoun T Metab Brain Dis. 2023; 38(8):2665-2678.

PMID: 37656370 DOI: 10.1007/s11011-023-01276-6.


The complement alternative pathway in paroxysmal nocturnal hemoglobinuria: From a pathogenic mechanism to a therapeutic target.

Risitano A, Frieri C, Urciuoli E, Marano L Immunol Rev. 2022; 313(1):262-278.

PMID: 36110036 PMC: 10087358. DOI: 10.1111/imr.13137.


How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.

Risitano A, Peffault de Latour R Br J Haematol. 2021; 196(2):288-303.

PMID: 34355382 PMC: 9291300. DOI: 10.1111/bjh.17753.